Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| uniQure N.V.QURE · Entity 4162 | Director · CEO, Managing Director | July 02, 2026 | July 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
uniQure N.V.
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 519,227 |
Ending reported balance
After 2026-07-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-07-02 · Exercise / conversion · Acquired 21,082 · Balance 540,309 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Row 2 · 2026-07-02 · Sale · Disposed 9,200 · Balance 531,109 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-07-02 · Sale · Disposed 4,282 · Balance 526,827 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-07-02 · Sale · Disposed 7,600 · Balance 519,227 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.39 · Expires 2028-01-26 | Direct | 0 |
Reported balance
After 2026-07-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-02 · Exercise / conversion · Disposed 21,082 · Balance 0 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5: The Stock Option vested in full on January 26, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The Stock Option vested in full on January 26, 2022.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Decibel Therapeutics, Inc.
Report date September 25, 2023 · Filed September 25, 2023
Section 16 reporting ended · disclosed 2023-09-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-09-25 transaction · row 1
1 source rowRow 1 · 2023-09-25 · Disposition to issuer · Disposed 10,000 · Balance 0 F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Regeneron Pharmaceuticals, Inc. ("Parent") and Symphony Acquisition Sub, Inc. ("Purchaser"), dated as of August 8, 2023, the shares of common stock, par value $0.001 per share, of the Issuer that were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) were exchanged for (i) $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Cash Consideration"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a "CVR"), F2: (Continued from Footnote 1) which entitles the holder to potentially receive contingent payments of up to an aggregate of $3.50 per CVR, without interest and subject to reduction for any applicable withholding taxes, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a Contingent Value Rights Agreement (the "CVR Agreement"), dated as of September 25, 2023, by and among Parent, Purchaser, Computershare Inc., and Computershare Trust Company, N.A. In addition, at the effective time of the merger (the "Effective Time"), pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each a "Company RSU"), whether or not vested, was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to such Company RSU multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such Company RSU. F3: Includes 10,000 unvested Company RSUs. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.34 · Expires 2033-03-18 | Direct | 0 |
Reported balance
After 2023-09-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-09-25 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the amount of the Cash Consideration (each a "Tranche 1 Option"), was cancelled and exchanged for (A) an amount in cash equal to the product of (x) the total number of shares subject to such Tranche 1 Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Cash Consideration over the applicable exercise price per share of such Tranche 1 Option, and (B) one CVR with respect to each share subject to such Tranche 1 Option as of immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Regeneron Pharmaceuticals, Inc. ("Parent") and Symphony Acquisition Sub, Inc. ("Purchaser"), dated as of August 8, 2023, the shares of common stock, par value $0.001 per share, of the Issuer that were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) were exchanged for (i) $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Cash Consideration"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a "CVR"),
F2: (Continued from Footnote 1) which entitles the holder to potentially receive contingent payments of up to an aggregate of $3.50 per CVR, without interest and subject to reduction for any applicable withholding taxes, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a Contingent Value Rights Agreement (the "CVR Agreement"), dated as of September 25, 2023, by and among Parent, Purchaser, Computershare Inc., and Computershare Trust Company, N.A. In addition, at the effective time of the merger (the "Effective Time"), pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each a "Company RSU"), whether or not vested, was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to such Company RSU multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such Company RSU.
F3: Includes 10,000 unvested Company RSUs.
F4: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the amount of the Cash Consideration (each a "Tranche 1 Option"), was cancelled and exchanged for (A) an amount in cash equal to the product of (x) the total number of shares subject to such Tranche 1 Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Cash Consideration over the applicable exercise price per share of such Tranche 1 Option, and (B) one CVR with respect to each share subject to such Tranche 1 Option as of immediately prior to the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,082 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · derivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 21,082 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested in full on January 26, 2022. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 7,600 | $45.89 | $348,764.00 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,227 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 4,282 | $45.43 | $194,531.26 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 526,827 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 9,200 | $44.43 | $408,756.00 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 531,109 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 21,082 | $19.39 | $408,779.98 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 540,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:15 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,716 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · derivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,862 Underlying: Ordinary Shares · 28,716 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on January 25, 2023. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 28,716 | $50.02 | $1,436,374.32 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,227 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:15 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 28,716 | $31.71 | $910,584.36 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 547,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 21:15 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,128 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · derivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,578 Underlying: Ordinary Shares · 4,128 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on January 25, 2023. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 21:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,696 | $50.00 | $334,800.00 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,227 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 21:15 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 4,128 | $31.71 | $130,898.88 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 525,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,656 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · derivative · entry 12 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,706 Underlying: Ordinary Shares · 4,656 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · derivative.exercise_date: The Stock Option vested in full on January 25, 2023. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 37,015 | $50.00 | $1,850,750.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 10 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 521,795 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.01. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 4,656 | $50.00 | $232,800.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 9 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 558,810 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.03. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 4,656 | $31.71 | $147,641.76 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 8 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 563,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 62,581 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · derivative · entry 11 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,082 Underlying: Ordinary Shares · 62,581 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F8 · derivative.exercise_date: The Stock Option vested in full on January 26, 2022. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 11,585 | $48.65 | $563,610.25 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 7 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 558,810 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 33,334 | $45.01 | $1,500,363.34 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 570,395 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.17. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 56,929 | $43.43 | $2,472,426.47 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 603,729 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 32,581 | $45.02 | $1,466,796.62 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 660,658 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,023 | $43.70 | $263,205.10 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 693,239 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.56 to $43.94. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 23,977 | $42.61 | $1,021,659.97 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 699,262 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $43.48. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 62,581 | $19.39 | $1,213,445.59 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 723,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 113,800 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000163 · edgar.xml · derivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,800 Underlying: Ordinary Shares · 113,800 shares Expires 2036-03-04 F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:07 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 14,581 | $9.06 | $132,103.86 |
DisclosureSEC source: 0000904454-26-000163 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 660,658 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 70,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000163 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 675,239 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:42 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 34,437 | $9.95 | $342,648.15 |
DisclosureSEC source: 0000904454-26-000154 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604,639 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:49 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 12,378 | $23.86 | $295,339.08 |
DisclosureSEC source: 0000904454-26-000141 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 639,076 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.64 to $24.06. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $6.22 | $0.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · derivative · entry 9 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 175,000 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · derivative.exercise_date: The Stock Option vested 25% on March 14, 2018 and 6.25% quarterly thereafter. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 51,316 | $0.00 Strike: $7.53 | $0.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · derivative · entry 8 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,316 shares Expires 2026-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · derivative.exercise_date: The Stock Option vested 25% on September 29, 2017 and 6.25% quarterly thereafter. F8 · balance_after: Adjusted to reflect the exercise and sale of 7,501 option shares under the Reporting Person's 10b5-1 plan on February 19, 2020. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 60,000 | $45.10 | $2,706,000.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 7 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 651,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 5,022 | $41.69 | $209,367.18 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 711,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.56 to $41.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 49,978 | $40.68 | $2,033,105.04 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 716,476 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.42 to $41.42 The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 60,000 | $40.04 | $2,402,400.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 766,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 51,316 | $39.59 | $2,031,600.44 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 826,454 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.20 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 175,000 | $6.22 | $1,088,500.00 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 877,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 23:43 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 51,316 | $7.53 | $386,409.48 |
DisclosureSEC source: 0000904454-25-000457 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 22:32 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 28,341 | $10.29 | $291,628.89 |
DisclosureSEC source: 0000904454-25-000182 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 651,454 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number os shares sold at each sparate price within the range set forth in the footnote. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:32 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 171,000 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0000904454-25-000182 · edgar.xml · derivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,000 Underlying: Ordinary Shares · 171,000 shares Expires 2025-03-03 F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:32 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 99,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-25-000182 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 679,795 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 00:33 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,717 | $11.32 | $76,036.44 |
DisclosureSEC source: 0000904454-25-000167 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,795 F4 · kind: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F4 · shares: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.28 to $11.42. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 00:33 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 16,324 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-25-000167 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587,512 F3 · shares: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on February 26, 2025 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 00:33 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 26,727 | $10.70 | $285,978.90 |
DisclosureSEC source: 0000904454-25-000167 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571,188 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.56 to $11.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:54 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0000904454-24-000650 · edgar.xml · derivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 100,000 shares Expires 2025-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025. F3 · derivative.exercise_date: The Stock Option vested 25% on January 2, 2016 and 6.25% quarterly thereafter. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:54 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 100,000 | $15.03 | $1,503,000.00 |
DisclosureSEC source: 0000904454-24-000650 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 597,915 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.14. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:54 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 100,000 | $14.71 | $1,471,000.00 |
DisclosureSEC source: 0000904454-24-000650 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 697,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:03 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 3,418 | $7.63 | $26,079.34 |
DisclosureSEC source: 0000904454-24-000644 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 597,915 F2 · kind: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of PRSUs solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Performance Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. Read SEC document |
| December 08, 2024 Filed Dec 10, 2024 22:03 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 10,494 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-24-000644 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,333 F1 · shares: Represents performance-based restricted share units ("PRSUs") granted to the Reporting Person on December 8, 2021 under the Issuer's 2014 Share Incentive Plan, as amended and restated, which were earned on December 8, 2024 as the result of the satisfaction of certain performance criteria. Each PRSU represents the contingent right to receive one Ordinary Share. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 259,500 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0000904454-24-000203 · edgar.xml · derivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,500 Underlying: Ordinary Shares · 259,500 shares Expires 2034-03-01 F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-24-000203 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,839 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.